|
Sotac Pharmaceuticals Ltd
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
143.48 Cr.
|
P/BV
|
3.04
|
Book Value (Rs.)
|
42.67
|
|
52 Week High/Low (Rs.)
|
203/88
|
FV/ML
|
10/1200
|
P/E(X)
|
17.88
|
|
Bookclosure
|
|
EPS (Rs.)
|
7.26
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 7.26 | 3.90 | 2.84 | 12.51 | -10.28 |
| Diluted EPS (Rs.) | 7.26 | 3.90 | 2.84 | 12.51 | -10.28 |
| Cash EPS (Rs.) | 11.86 | 6.04 | 5.67 | 17.41 | 0.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 48.19 | 44.64 | 12.69 | 28.79 | 11.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 48.19 | 44.64 | 12.69 | 28.79 | 11.16 |
| Revenue From Operations / Share (Rs.) | 87.77 | 93.96 | 96.25 | 318.05 | 212.36 |
| PBDIT / Share (Rs.) | 15.87 | 8.15 | 9.44 | 27.62 | 6.79 |
| PBIT / Share (Rs.) | 12.40 | 5.34 | 6.61 | 22.73 | -4.49 |
| PBT / Share (Rs.) | 10.06 | 3.59 | 4.88 | 20.41 | -8.94 |
| Net Profit / Share (Rs.) | 8.39 | 3.24 | 2.84 | 12.52 | -10.28 |
| NP After MI And SOA / Share (Rs.) | 7.26 | 3.24 | 2.84 | 12.52 | -10.28 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 18.07 | 8.66 | 9.80 | 8.68 | 3.19 |
| PBIT Margin (%) | 14.12 | 5.68 | 6.86 | 7.14 | -2.11 |
| PBT Margin (%) | 11.46 | 3.81 | 5.06 | 6.41 | -4.21 |
| Net Profit Margin (%) | 9.56 | 3.44 | 2.95 | 3.93 | -4.84 |
| NP After MI And SOA Margin (%) | 8.27 | 3.44 | 2.95 | 3.93 | -4.84 |
| Return on Networth / Equity (%) | 15.07 | 7.90 | 22.88 | 43.47 | -94.85 |
| Return on Capital Employeed (%) | 18.82 | 9.58 | 19.12 | 68.34 | -8.64 |
| Return On Assets (%) | 6.45 | 3.39 | 3.10 | 8.16 | -6.81 |
| Long Term Debt / Equity (X) | 0.26 | 0.26 | 0.77 | 0.14 | 3.72 |
| Total Debt / Equity (X) | 0.82 | 0.54 | 2.21 | 1.12 | 6.87 |
| Asset Turnover Ratio (%) | 0.84 | 1.16 | 1.29 | 2.09 | 1.66 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.35 | 1.39 | 1.03 | 0.93 | 0.76 |
| Quick Ratio (X) | 0.96 | 0.97 | 0.73 | 0.74 | 0.55 |
| Inventory Turnover Ratio (X) | 3.29 | 4.91 | 5.71 | 10.99 | 11.22 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 15.97 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 11.48 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 84.03 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 88.52 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 6.80 | 5.28 | 3.85 | 11.94 | 1.52 |
| Interest Coverage Ratio (Post Tax) (%) | 4.60 | 3.24 | 1.86 | 6.41 | -1.31 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 178.52 | 159.22 | 0.00 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 1.84 | 1.53 | 0.00 | 0.00 | 0.00 |
| EV / EBITDA (X) | 10.18 | 17.69 | 0.00 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.35 | 1.29 | 0.00 | 0.00 | 0.00 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 84.02 | 0.00 |
| Price / BV (X) | 2.46 | 2.95 | 0.00 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 1.35 | 1.29 | 0.00 | 0.00 | 0.00 |
| EarningsYield | 0.06 | 0.02 | 0.00 | 0.00 | 0.00 |
